Navigation Links
Acella Pharmaceuticals, LLC, files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration for Topical Corticosteroids Lotion
Date:7/10/2012

ATLANTA, July 10, 2012 /PRNewswire/ -- Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, announces the submission of an Abbreviated New Drug Application (ANDA) to the Food and Drug Administration (FDA) for a Topical Corticosteroids Lotion.

Mark Pugh, CEO of Acella Pharmaceuticals, commented, "Our R&D team has done a tremendous job in effectively managing our development projects, resulting in an extensive product pipeline. This filing represents Acella's sixth ANDA filed with the FDA. We expect to file additional ANDAs this year to bring our total to 11 ANDA submissions by the end of 2012."

"We look forward to working with the FDA to get this product approved, on the market, and to our customers," stated Allen Fields, Acella Pharmaceuticals' Vice President, Head of Research and Development. "We continue to meet the objectives of our development strategy by finding the right products to assist patients with managing their health care costs."

About Acella Pharmaceuticals, LLC.

Acella develops, markets, sells and distributes a broad portfolio of non-branded pharmaceutical and other products in the areas of Dermatology, Women's Health, Pediatrics and other applications. Acella specializes in identifying and bringing to market quality, affordable products to customers and patients. For additional information please contact Acella at 678-325-5189.


'/>"/>
SOURCE Acella Pharmaceuticals, LLC
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Acella Pharmaceuticals Announces a New Addition to the Commercial Team
2. Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
3. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
4. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
5. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
6. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
7. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
8. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
9. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
10. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
11. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... PAUL, Minn. , June 17, 2013 Prime ... branding and design agency, Larsen, was awarded the Silver Anvil ... Repositioning Prime Therapeutics." The award was presented at the Public ... Ceremony held June 13 at the AXA Equitable ... The Silver Anvil, which has been presented annually ...
(Date:6/17/2013)... , June 17, 2013 /PRNewswire-iReach/ -- Weiler ... company,s new X-4S pressure sensitive labeling head. The ... speed and performance requirements that serialization demands. ... WLS is uniquely qualified to work with pharmaceutical ... their serialization and track and trace implementation strategies. ...
(Date:6/17/2013)... Mass. and TORONTO , ... ) (OTCBB:GNBT) today announced that it entered into a ... 17, 2013.  The investors have agreed to purchase in ... the Company,s newly designated non-voting Series E 9% Convertible ... up to an aggregate of 100% of the shares ...
Breaking Medicine Technology:Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America 2Weiler Labeling Introduces Serialization-Capable X-4S Labeling Head 2Generex Announces $1,225,000 Capital Investment 2Generex Announces $1,225,000 Capital Investment 3Generex Announces $1,225,000 Capital Investment 4Generex Announces $1,225,000 Capital Investment 5
... 2011  IRIDEX Corporation (Nasdaq: IRIX ) today ... 10 years demonstrates the safety and efficacy of MicroPulse ... the retina tissue damage associated with conventional laser therapy.  ... and Prevention, DME, a swelling of retinal tissue, is ...
... Reportlinker.com announces that a new market ... Global Medical Ultrasound ... http://www.reportlinker.com/p098401/Global-Medical-Ultrasound-Equipment-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_I This report analyzes ... in US$ Million by the following End-Use ...
Cached Medicine Technology:10-Year Study Demonstrates IRIDEX MicroPulse™ Laser Therapy Safe, Effective for Patients with Diabetic Macular Edema 210-Year Study Demonstrates IRIDEX MicroPulse™ Laser Therapy Safe, Effective for Patients with Diabetic Macular Edema 3Global Medical Ultrasound Equipment Industry 2Global Medical Ultrasound Equipment Industry 3Global Medical Ultrasound Equipment Industry 4Global Medical Ultrasound Equipment Industry 5Global Medical Ultrasound Equipment Industry 6Global Medical Ultrasound Equipment Industry 7Global Medical Ultrasound Equipment Industry 8Global Medical Ultrasound Equipment Industry 9Global Medical Ultrasound Equipment Industry 10Global Medical Ultrasound Equipment Industry 11Global Medical Ultrasound Equipment Industry 12Global Medical Ultrasound Equipment Industry 13Global Medical Ultrasound Equipment Industry 14Global Medical Ultrasound Equipment Industry 15Global Medical Ultrasound Equipment Industry 16Global Medical Ultrasound Equipment Industry 17Global Medical Ultrasound Equipment Industry 18Global Medical Ultrasound Equipment Industry 19Global Medical Ultrasound Equipment Industry 20Global Medical Ultrasound Equipment Industry 21Global Medical Ultrasound Equipment Industry 22Global Medical Ultrasound Equipment Industry 23Global Medical Ultrasound Equipment Industry 24Global Medical Ultrasound Equipment Industry 25
(Date:6/18/2013)... clinical researchers have launched an innovative clinical trial, ... ability of a patient,s own stem cells to ... disease (PAD). , Led by Vik Kashyap, ... Case Medical Center,s Harrington Heart & Vascular Institute ... University School of Medicine, the clinical trial is ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The July 2013 ... Cheater’s Guide to Getting Beach Ready,” offers a list of ... look their best in a bathing suit this summer. The ... skin firming , smoothing cellulite , and more. (go ... Ourian, Medical Director of Epione Beverly Hills, “though I would ...
(Date:6/18/2013)... Healthcare Solutions , the parent ... today announced the appointment of Richard Leonardo to ... position, Leonardo will direct Healthcare Solutions’ national sales ... initiatives. , Recognized in the property and casualty ... more than 20 years of experience in business ...
(Date:6/18/2013)... Calif. (PRWEB) June 18, 2013 David ... professor of Family Medicine for the College of Osteopathic ... Health Sciences has been elected president of the ... Edmund G. Brown Jr. appointed Connett, a 1984 alumnus ... OMBC members recently elected Connett to the position during ...
(Date:6/18/2013)... the mammary gland appear to provide a crucial link ... and the subsequent development of breast cancer, researchers from ... issue of the journal Cancer Prevention Research . ... with an increased risk of certain types of aggressive ... social stress to cancer have been hard to identify. ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Skin Care – Getting Your Body Beach Ready 2Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4
... fatty liver disease (NAFLD) and non-alcoholic steatohepatitis ... disease leading to cirrhosis and hepatocellular carcinoma. ... significant efficacy in these conditions and no ... the renin-angiotensin system overexpression plays a central ...
... and family can pave the way to sporting victory, according ... Kelly Holmes and Sir Chris Hoy have both cited the ... factor in their Olympic success. Now, for the first time, ... on sports performance. , Published in the Journal ...
... Jeff Bingaman (D-NM) received the 2009 Outstanding Leadership ... (APAPO) for his advocacy work and legislative accomplishments ... given to a member of Congress who has ... Bingaman has been a tireless crusader of mental ...
... in the Diagnosis and Assessment of AsthmaEXTON, Pa., March ... Pharmaxis Ltd (ASX: PXS, Nasdaq: PXSL ), ... it has filed a New Drug Application (NDA), electronically, ... Aridol(TM) (mannitol bronchial challenge test). Bronchial challenge tests ...
... B. Snow Jr., chairman and chief executive officer, Medco ... scheduled to address the Barclays Capital Global Healthcare Conference ... the Loews Miami Beach Hotel, South Beach, will begin ... officer, is also scheduled to attend.The presentation may be ...
... Specially trained vets are using ancient treatment to fight ... After surgery for a ruptured disk two years ago, ... became lethargic and lost her appetite. , Things were ... 10-year-old to an acupuncturist, who treated her three times ...
Cached Medicine News:Health News:Is telmisartan effective in treating non-alcoholic steatohepatitis? 2Health News:Is telmisartan effective in treating non-alcoholic steatohepatitis? 3Health News:Study shows why sporting heroes should thank their friends 2Health News:Pharmaxis Announces NDA Filing for Aridol(TM) (Mannitol Bronchial Challenge Test) 2Health News:Medco CEO to Present at the Barclays Capital Global Healthcare Conference 2Health News:Animals Respond to Acupuncture's Healing Touch 2Health News:Animals Respond to Acupuncture's Healing Touch 3Health News:Animals Respond to Acupuncture's Healing Touch 4
Bi-Directional doppler volume flowmeter....
... frequency and multigate transcranial ... and fitted with a ... for hemodynamic evaluation. Looki ... well for routine diagnosis ...
One channel, one gate transcranial Doppler that is diagnosis oriented with an advanced protocol editor, automatic report generator and a powerful examination data base....
One channel transcranial Doppler...
Medicine Products: